Загрузка...
A Liposomal Drug Platform Overrides Peptide Ligand Targeting to a Cancer Biomarker, Irrespective of Ligand Affinity or Density
One method for improving cancer treatment is the use of nanoparticle drugs functionalized with targeting ligands that recognize receptors expressed selectively by tumor cells. In theory such targeting ligands should specifically deliver the nanoparticle drug to the tumor, increasing drug concentrati...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Public Library of Science
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3751880/ https://ncbi.nlm.nih.gov/pubmed/24009717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0072938 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|